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ABSTRACT
Inflammation plays a key role in human term and preterm
labor (PTL). Intrauterine LPS has been widely used to model
inflammation-induced complications of pregnancy, including
PTL. It has been shown to induce an intense myometrial
inflammatory cell infiltration, but the role of LPS-induced
inflammatory cell activation in labor onset and fetal demise is
unclear. We investigated this using a mouse model of PTL, where
an intrauterine injection of 10 lg of LPS (serotype 0111:B4) was
given at E16 of CD1 mouse pregnancy. This dose induced PTL at
an average of 12.7 h postinjection in association with 85% fetal
demise. Flow cytometry showed that LPS induced a dramatic
systemic inflammatory response provoking a rapid and marked
leucocyte infiltration into the maternal lung and liver in
association with increased cytokine levels. Although there was
acute placental inflammatory gene expression, there was no
corresponding increase in fetal brain inflammatory gene
expression until after fetal demise. There was marked myome-
trial activation of NFjB and MAPK/AP-1 systems in association
with increased chemokine and cytokine levels, both of which
peaked with the onset of parturition. Myometrial macrophage
and neutrophil numbers were greater in the LPS-injected mice
with labor onset only; prior to labor, myometrial neutrophils and
monocytes numbers were greater in PBS-injected mice, but this
was not associated with an earlier onset of labor. These data
suggest that intrauterine LPS induces parturition directly,
independent of myometrial inflammatory cell infiltration, and
that fetal demise occurs without fetal inflammation. Intrauterine
LPS provokes a marked local and systemic inflammatory
response but with limited inflammatory cell infiltration into
the myometrium or placenta.
chemokines, inflammation, leucocytes, lungs, myometrium
INTRODUCTION
Normal labor is an inflammatory process with many studies
showing an increased infiltration of myeloid leukocytes to the
uterus around the time of labor [1–3]. In rodent models of
pregnancy, an increase in leucocyte cell numbers can also be
detected in the decidua and/or myometrium during late
gestation prior to labor [4–7]. Along with localized inflamma-
tion in the uterus, an increase in monocyte and neutrophil
numbers has been reported in the circulation of laboring
women compared to women at term, while the activation status
of the systemic monocyte population has been found to be
increased throughout pregnancy [8]. However, it is not clear
how the inflammatory pathways involved in the initiation of
labor at term are different from the infection/inflammatory
induced preterm labor (PTL). Preterm birth is defined as
delivery prior to 37 wk of gestation and results in the death of
over 1 million babies annually [9]. PTL is the most important
cause, accounting for over 66% of cases. Current treatment
involves the use of tocolytics to delay delivery, allowing
sufficient time for the administration of antenatal steroids to
promote fetal lung maturation; however, long-term neonatal
outcomes are not improved by this approach [10]. This is
perhaps because intrauterine infection is a common cause of
PTL, and prolonging gestation in an infected/inflammatory
environment may cause greater harm to the fetus [11].
Many attempts have been made to model inflammation-
induced labor, and it has been almost 20 yr since the original
description of the use of intrauterine administration of
Escherichia coli to induce PTL in the mouse [12]. This model
was later adapted by Elovitz et al. [13] in 2003 using 250 lg
LPS (O55:B5); although this reliably induced PTL within 48 h,
it caused 100% fetal mortality. Using this model of infection-
induced PTL, it has been possible to investigate leucocyte
infiltration and chemokine levels in the uterus prior to and
during PTL. Rinaldi et al. [14] showed that neutrophil
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chemokine expression levels and neutrophil numbers increased
in the uterus following surgery, and labor induced by
intrauterine LPS has been shown to have an exaggerated
increase in cytokines in the myometrium compared to normal
term labor and non-infection-induced PTL [6]. LPS acts via
activation of toll-like receptors (TLRs), typically TLR4, which
in turn activate the inflammatory cascade of transcription
factors, triggering the release of chemokines, cytokines, and
prolabor genes [15, 16]. The importance of the TLR4-
chemokine system is shown by the failure of Gram-negative
bacteria to induce PTL in TLR4 mutant mice and in wild-type
mice after blocking chemokine receptors [17, 18]. We have
previously shown that LPS increases COX-2 and Connexin 43
levels and induces labor in a JNK-dependent manner [16, 19].
In this study, we have used flow cytometry to investigate the
changes in leucocyte kinetics locally in the uterus and placenta
and systemically in the circulation, lung, and liver to
understand the role that immune cells and immune modulators
play in the onset of LPS-induced PTL in the mouse model.
Specifically, we have tested the hypothesis that there is a
relationship between labor onset, fetal demise, and changes in
leucocyte populations in reproductive tissues and systemic sites
in the murine model of intrauterine LPS-induced PTL.
MATERIALS AND METHODS
Animal Study Ethical Statement and Husbandry Conditions
CD1 outbred mice were purchased from Charles River at 6–8 wk of age and
subsequently housed in open cages at 21 6 18C on a 12L:12D cycle and given
Harlan Teklad 2018 Global Diet rodent food and water ad libitum. Female mice
were mated overnight with males, and the day a copulatory plug was observed
was designated Embryonic Day 0 (E0). Stud males were singly housed, while
females were group housed (up to five dams per cage) prior to surgery, after
which time they were singly housed to litter down.
The health status of all animals was monitored daily, and all mice due to
enter a treatment arm were inspected prior to initiation of the protocol. Animals
were monitored by infrared CCTV (RF Concepts) postsurgery and physical
inspection in the lead-up to labor in case of laboring complications.
All experiments were performed in accordance with the Animals (Scientific
Procedures) Act 1986, under Home Office Licenses 70/6909 and 70/7518, with
approval from the Animal Welfare and Ethical Review Boards of Imperial
College and University College London. The 3Rs and ARRIVE guidelines
were consulted and implemented in completion of this study and in the
production of this article.
LPS-Induced Preterm Labor Model
When we established the LPS model in the group, we tested various
serotypes [19] before deciding on the 0111 serotype. We also performed a
dose-response curve deciding on the 10-lg dose as the being the dose that gave
reliable rates of PTL with the lowest rates of maternal morbidity and mortality
with some fetal survival. This dose gave similar rates of PTL as a 2–103 103
dose of live E. coli [12]. The mouse model of inflammation-induced PTL is
now well established in our group [19]. Briefly, on Day 16 of gestation (E16),
dams were given a subcutaneous injection of morphine (5 mg/kg) to provide
suitable analgesia for a minilaparotomy performed under isoflurane anesthesia
(5% isoflurane in oxygen at a 1.5-L/min flow rate). The uterine horns were
exteriorized and kept moist with sterile PBS in a sterile swab. Intrauterine
injections were performed on the right uterine horn between the first and
second uppermost fetuses with care not to enter either amniotic cavity. Ten
micrograms of E. coli LPS serotype 0111:B4 (Sigma) in a total volume of 25 ll
or sterile PBS (25 ll) were injected. Each fetus was checked for viability before
the uterine horns were replaced into the abdomen. Bupivicaine (2 mg/kg) was
applied to the muscle layer and skin of the abdomen during suturing for further
analgesia. Mice were allowed to recover in a heated recovery chamber,
followed by single housing and regular monitoring, prior to euthanization and
tissue collection. Labor time was calculated from the time of injection to the
delivery of one or more fetuses. Fetal health status was assessed immediately
on confirmation of the dam’s death and prior to tissue collection. Blood and
tissue samples, including lung, liver, myometrium, placenta, and fetal brains
from the left uterine horn, were obtained at 3 and 7 h postinjection and after the
birth of at least the first fetus, as initial studies suggested that delivery occurred
at about 12 h post-LPS administration. Blood and tissue samples were either
snap frozen for molecular analysis or processed immediately for flow
cytometry.
Animals were selected for LPS or vehicle control administration randomly,
with both groups injected alongside each other during every surgical session, to
avoid bias. Surgeries were performed at the same time during each
experimental session (between 1000 and 1200 h) to ensure that the gestational
stage was as similar as possible between mice, thus reducing variation in the
model. Intermediate collection time points were determined once the latency to
labor post-LPS administration was calculated. Due to pregnancy rates and to
again avoid collection bias, multiple time point collections were performed on
the same day, while laboring samples were collected over various days. We
mated enough animals to ensure that we had a minimum of six animals at each
time point. The sample size was chosen based on previous in vivo work [16,
19] and the requirements for statistical normality testing. When the mating
proved to be more successful than expected, we used the excess animals to
increase numbers at the different time points. A single pregnant dam represents
a single experimental unit throughout this study.
Tissue Collection, Cell Preparation, and Flow Cytometry
Dams were culled via exsanguination by cardiac puncture, followed by
immediate cervical dislocation. Blood was immediately mixed with 5 mM
EDTA and stored at 48C until analysis within 12 h. The lungs, sections of liver,
myometrium, and placentas were immediately collected and weighed. Each
tissue was homogenized using a gentleMACS M tube (Miltenyi Biotec Ltd)
containing 1 ml of IC fixation buffer (eBioscience) for 1 min. The homogenate
was then strained through a 40-lm nylon cell strainer (BD Falcon), and the cell
suspension was then centrifuged at 4003 g for 5 min. Cells were then washed
in PBS-FCS 2% and resuspended in permeabilizing medium PBS, 0.1%
sodium azide, 0.5% BSA, and 0.2% saponin and then incubated with antibodies
at 48C for 30 min.
The fluorophore-conjugated rat antimouse MAbs antibodies used included:
Ly6C (HK1.4), Gr1 (RB6-8C5), NK1.1 (PK136), F4/80 (CI:A3-1), CD45 (30-
F11) (BioLegend), COX-2 (M-19) (Santa Cruz Biotechnology), CD86 (B7-2),
CD11b (M1/70), MHCII (AMS-32.1), and F4/80 (BM8) (eBioscience). Levels
of CD86 and COX-2 were calculated after subtraction of an isotype-matched
control antibody to calculate MFI levels (IgG2a K Isotype Control [eBR2a,
eBioscience catalog no. 12-4321]).
In the case of F4/80, two different antibodies were used in two separate
flow panels. The cell counts were comparable between the two panels. For any
data with CD86 or COX-2, MFI:F4/80 (BM8) (eBioscience catalog no.
123116) was used and for all other cell counts: F4/80 (BM8) (BioLegend
catalog no. 123110) was used. The antibody was derived from the same clone
but linked to different fluorophores.
After staining, lysis of red blood cells was performed using FACS lysing
solution (BD). Cell counts were determined using AccuCheck counting beads
(Invitrogen). Samples were run using a CyAn ADP Beckman Coulter flow
cytometer following compensation with normal mouse blood using Summit
software. Data were analyzed using FlowJo version 7.6.5.
Tissue Collection, Preparation, and Bio-Plex Pro Multiplex
Cytokine and Cell Signaling Assays
Tissue lysates were prepared using myometrium and lung tissue snap frozen
at the time of collection using a Bio-Plex Cell Lysis kit (BioRad) and a
Precellys24 (Stretton Scientific Ltd) bead homogenizer according to the
manufacturer’s instructions. Total protein concentrations were quantified using
a DC Protein Assay (BioRad). Whole blood was mixed with 5 mM EDTA
immediately after cardiac puncture and centrifuged at 1000 3 g for 15 min.
Aliquots of plasma were stored at 708C until assayed.
Twenty-five microliters of plasma or 250 lg of total protein lysate were
added per well to a Bio-Plex Pro Mouse Cytokine 23-plex Assay and
completed according to the manufacturer’s instructions. Analytes measured
include Eotaxin, G-CSF, GM-CSF, IFNc, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5,
IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL17A, KC, CCL2, MIP-1a,
MIP-1b, RANTES, and TNFa.
Levels of phosphorylated cell signaling proteins were analyzed using a Bio-
Plex ProT cell signaling multiplex assay (BioRad). Ten micrograms of the
protein lysate were incubated for 16 h with magnetic antibody-tagged beads,
according to the manufacturer’s instructions. Transcription factors analyzed
included phosphorylated c-June (Ser63) and phosphorylated nuclear factor-jB
(NFjB) p65 (Ser536). The MAPK/AP-1 pathway was assessed by measuring
phosphorylated mitogen-activated protein kinase kinase 1 (MEK-1) (Ser217/
Ser221), phosphorylated extracellular signal-regulated kinase (ERK)1/2
(Thr202/Tyr204, Thr185/Tyr187), phosphorylated p38 (Thr180/Tyr182), and
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phosphorylated JNK (Thr183/Tyr185). The data are expressed as a ratio of mean
fluorescence intensity of a sample to mean fluorescence intensity of the positive
control. The positive control was supplied by the manufacturer for each of the
analytes. Cytokine and cell-signaling plates were analyzed using Bio-Plex
Magpix multiplex reader and Bio-Plex Manager version 6.1 software (BioRad).
BrdU Injection
To label dividing cells in vivo, 100 ll of 10-mg/ml BrdU (BD Pharmingen)
in sterile PBS was administered by i.p. injection. Previous kinetic studies
demonstrated Brdu labeling of bone-marrow-derived Ly6Chigh monocytes is
maximal after 18 h [20] and that at 24 h after BrdU injection in E7.5 mice,
.50% of the Ly-6Chigh monocytes in the circulation and in the myometrium
were BrdU positive [21]. Therefore, to assess monocyte infiltration into the
myometrium, we performed the laparotomy and intrauterine PBS injection at
17 h post-BrdU injection and tissues collected 7 h later at 24 h post-BrdU.
Quantitative RT-PCR Analysis
Total RNA was extracted from tissue using an RNeasy kit and Qiashredder
(Qiagen Ltd). The concentration of RNA in each sample was measured by a
NanoDrop ND1000 spectrophotometer (ThermoFisher Scientific). One micro-
gram of RNA was converted to cDNA using the MuLV reverse transcriptase
system (Applied Biosystems Ltd.), according to manufacturer’s protocols.
Primer sets were designed using Primer3 software and obtained from Life
Technologies Ltd. (Table 1). Quantitative PCR was performed in the presence
FIG. 1. A) Delivery time after intrauterine injection of PBS or LPS (10 lg
of E. coli LPS serotype 0111:B4). Delivery time was recorded when at least
one fetus had been delivered. For naive mice in spontaneous labor, time to
delivery was recorded from 0900 h on E16. For the mice given an
intrauterine injection, delivery time was counted in hours from the time of
the laparotomy. The data are expressed as median interquartile range.
Data were not normally distributed and were analyzed using a Kruskal-
Wallis test with a Dunn multiple comparison posttest (****P, 0.0001; n¼
16–37). B) Fetal survival after intrauterine injection of PBS or LPS (10 lg of
E. coli LPS serotype 0111:B4). Fetal survival is defined as the number of
fetuses born alive at delivery. The data are expressed as median
interquartile range. Data were not normally distributed and were analyzed
using a Kruskal-Wallis test with a Dunn multiple comparison posttest
(****P , 0.0001; n¼ 16–37).
FIG. 2. A–F) Cell density of leukocytes in the myometrium and myometrial macrophage activation status in untreated mice on E16 and following a
laparotomy and intrauterine injection of either PBS or LPS (10 lg of E. coli LPS serotype 0111:B4) at 7 h postprocedure and in labor. Cell densities of Ly6chi
and Ly6clo monocytes (CD11bþ, F/80þ), neutrophils (CD11bþ, Ly6Gþ), and myometrial macrophages (CD11bþ, F4/80þþ, Ly6Clo) and activation status
of myometrial macrophages at each time point are expressed as median interquartile range. When the data were normally distributed, they were analyzed
using a one-way ANOVAwith Bonferroni posttest, and when the data were not normally distributed, they were analyzed using a Kruskal-Wallis test with a
Dunn multiple comparison posttest (*P , 0.05, **P , 0.01, ***P , 0.001, ****P , 0.0001; n¼ 6–12).
IMMUNE RESPONSE TO INTRAUTERINE LPS
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of SYBR Green (Roche Diagnostics Ltd.), and amplicon yield was monitored
by Rotor Gene R-G 3000 (Corbett Research).
Statistical Analysis
All data were tested for normality using a Kolmogorov-Smirnoff test.
Normally distributed data were analyzed using a Student t-test for two groups
and an ANOVA followed by a Bonferroni post hoc test for three groups or
more. Data that were not normally distributed were analyzed using a Mann-
Whitney test for unpaired data and, when comparing three groups or more, a
Kruskal-Wallis test with a Dunn multiple comparisons post hoc test; P , 0.05
was considered statistically significant.
RESULTS
Laparotomy and intrauterine injection of LPS on E16
induced preterm parturition in 12.7 6 7 h, compared to 57.5 6
16 h (P, 0.001) in the surgical sham control group and 58.5 þ
3.4 (P , 0.001) in the naive group (Fig. 1A). At labor, after
intrauterine LPS, about 14.6 6 31% of the fetuses were alive,
and after PBS intrauterine injection, 83 6 25% of the fetuses
were alive (P , 0.0001; Fig. 1B). In naive controls, 100% of
the fetuses were alive.
Leukocyte Trafficking in the Intrauterine LPS Model of
Preterm Labor
At 7 h post-LPS injection, densities of the ‘‘inflammatory’’
Ly-6CHI subset of monocytes in the myometrium were
unchanged compared to E16 controls, whereas a substantial
increase in this population was found in sham PBS-injected
mice (Fig. 2A). These unexpected results were mirrored by
neutrophils, where, again, levels increased considerably in
sham mice compared to LPS-treated mice, although the latter
were higher than in E16 untreated controls (Fig. 2D). During
labor in LPS-treated mice, neutrophil cell density in the
myometrium was higher compared to labor in the sham group.
Although resident macrophage (CD11bþ, F4/80HI) densities
remained relatively constant in the different groups, elevated
CD86 expression suggested that these cells were activated
during LPS-induced labor compared to vehicle controls (Fig.
2F).
In view of the several-fold increase in Ly-6CHI cells
associated with myometrial tissue at 7 h postsurgery and PBS
injection, we wanted to confirm whether these represented an
infiltrating blood-derived monocyte population or only a
subpopulation of resident macrophages with elevated expres-
sion of the Ly-6C antigen. We performed in vivo BrdU
labeling as a method to identify vascular Ly-6CHI monocytes
recently mobilized from the proliferating bone marrow pool
[22]. BrdU was injected 24 h before harvest of tissue at the
postintrauterine PBS 7-h time point. We found that ;40% of
the myometrial Ly-6CHI cells were BrdU positive, suggesting
that these cells were derived from vascular Ly-6CHI monocyte
pool (Supplemental Fig. S1, A and C; Supplemental Data are
available online at www.biolreprod.org). Only minor labeling
of resident macrophages was observed (Supplemental Fig. S1,
B and D), indicating a relatively low rate of cell proliferation in
the myometrium.
The leukocyte profiles in the blood of both PBS- and LPS-
injected mice 7 h postlaparotomy were indicative of systemic
inflammation (Fig. 3, A–C), showing a monocytopenia and a
FIG. 3. Cell counts and density of leukocytes in the circulation (A–C, n¼ 4–10) and placenta (D–G, n¼ 6–8) of untreated mice on E16 and following a
laparotomy and intrauterine injection of either PBS or LPS (10 lg of E. coli LPS serotype 0111:B4) at 7 h postprocedure and in labor. Cell densities at each
time point are expressed as median interquartile range. When the data were normally distributed, they were analyzed using a one-way ANOVA with
Bonferroni posttest, and when the data were not normally distributed, they were analyzed using a Kruskal-Wallis test with a Dunn multiple comparison
posttest (*P , 0.05, **P , 0.01, ***P , 0.001, n¼ 6–12).
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concomitant neutrophilia. However, levels of leukocytes in the
placenta did not appear to be significantly altered by surgery
with or without LPS treatment (Fig. 3, D–G). Instead, the
vascular response to intrauterine LPS was most evident from
the marked increase in Ly-6CHI monocyte and neutrophil
numbers in the lungs and liver at 7 h (Fig. 4, A–G), most likely
marginated in capillaries, as previously described with
systemic LPS injection [23]. Furthermore, increased expression
of CD86 in interstitial lung macrophages (F4/80, MHCIIþ,
Ly6Clow) suggested activation of this population in intrauterine
LPS-injected mice (Supplemental Fig. S2). Therefore, although
intrauterine LPS produces limited leukocyte infiltration into the
uterus, it has a marked systemic effect.
The Effect of Intrauterine LPS on Local and Systemic
Cytokines
In order to investigate the mechanisms controlling leukocyte
trafficking in the LPS-induced PTL model, we measured the
myometrial (Fig. 5, A–H) and circulating (Fig. 6, A–H) levels
of chemokines and cytokine at 3 and 7 h post-LPS and during
labor. Virtually all were elevated at each time point in both
compartments compared to PBS controls (Figs. 5 and 6).
However, this was not reflected in a greater myometrial
monocyte and neutrophil infiltration, as described above,
possibly due to the reduction in chemokine gradient caused
by the elevated circulating levels. Laparotomy and PBS
injection alone increased CCL2, IL-6, and IL-1b levels in the
myometrium at 3 h (,0.0001, 0.0050, and ,0.0001,
respectively), but by 7 h post-PBS, chemokine and cytokine
levels were comparable to naive controls (Figs. 5 and 6).
Pulmonary tissue cytokine levels were also significantly
increased in the LPS-treated dams compared to PBS controls, the
CCL2 specifically perhaps accounting for the increased mono-
cyte cell numbers (Supplemental Fig. S3, A–H). The elevated
inflammatory cytokines confirmed the presence of significant
inflammation in lung tissue (Supplemental Fig. S3, A–D).
No Evidence of Fetal Brain Inflammation Prior to Fetal
Death
In this part of the study, in mice injected with intrauterine
LPS, 100% of the fetuses were alive at 3 h, 44% at 7 h, and 0%
at labor; in contrast, all of the fetuses of the mice injected with
intrauterine PBS were alive at each time point. Despite this,
fetal brain chemokine and cytokine mRNA expression levels
were generally lower in the fetuses of the mice receiving LPS
at 3 and 7 h. However, during labor, when 100% of the fetuses
of the mice receiving LPS were dead, levels of CCL2, CCL5,
CCL20, CXCL1, and TNFa in the LPS-injected mice were
found to be increased compared to PBS-injected controls
(Supplemental Fig. S4, A–C).
Placental Inflammation Increases Progressively Post-
Intrauterine LPS Infection
In contrast to the fetal brain samples, inflammation in the
placenta, as shown by increased chemokine and cytokine
FIG. 4. Cell counts and density of leukocytes in the lungs (A–D, n¼ 6–8) and liver (E–G, n¼ 6–9) of untreated mice on E16 and following a laparotomy
and intrauterine injection of either PBS or LPS (10 lg of E. coli LPS serotype 0111:B4) at 7 h postprocedure and in labor. Cell densities at each time point
are expressed as median interquartile range. When the data were normally distributed, they were analyzed using a one-way ANOVA with Bonferroni
posttest, and when the data were not normally distributed, they were analyzed using a Kruskal-Wallis test with a Dunn multiple comparison posttest (*P,
0.05, ***P , 0.001, ****P , 0.0001, n¼ 6–12).
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mRNA expression, increased progressively in LPS-injected
mice compared to PBS controls (Supplemental Fig. S4, D–F).
Activation of Signal Transduction Pathways
After LPS injection, the MAPK/AP-1 pathway was
activated, with increased phosphorylation of MEK1 and p38
at 3 h post-LPS (Fig. 7, A and E). ERK1/2 increased slightly
and nonsignificantly at 3 h and then declined and was
significantly lower in labor than the 3-h peak (Fig. 7C). JNK
showed a progressive decline in phosphorylation (Fig. 7G).
Phospho-cJun behaved in a similar fashion to ERK1/2, with a
nonsignificant increase at 3 h and then a decline to a
significantly lower level in labor than at the 3-h peak (Fig.
7I). In contrast to the MAPK/AP-1 system, phospho-p65 levels
increase progressively, peaking in labor (Fig. 7K). In addition,
at 7 h and in labor, phospho-p65 levels were higher in LPS-
treated mice compared to PBS controls (Fig. 7L).
DISCUSSION
This study shows that intrauterine LPS causes marked
systemic inflammation that promotes leucocyte infiltration into
the lungs and liver but with relatively little myometrial or
placental infiltration until the onset of parturition. This is
associated with increased circulating and myometrial cyto-
kines, the latter associated with activation of the NFjB and
MAPK/AP-1 pathways. Fetal death occurred in the absence of
any increased fetal brain cytokine expression prior to death but
with evidence of placental inflammation.
The lower numbers of infiltrating neutrophils and Ly-6CHI
monocytes in the myometrium at 7 h in LPS-injected compared
to PBS-treated mice did not mean less inflammation; indeed, at
3 h after LPS injection, myometrial activation of NFkB and
cytokine levels were much greater than in PBS-injected mice.
Similarly, systemic inflammation, demonstrated by plasma
chemokine and cytokine protein levels, was also significantly
increased. The high levels of cytokines in both compartments
were sustained from 3 h to the onset of labor. The marked
leucocyte infiltration into the lungs was associated with
increased local levels of cytokines at 7 h post-intrauterine
LPS challenge, suggesting that the response of the innate
immune system to the intrauterine LPS may be associated with
significant lung damage. Our group has previously shown that
a subclinical endotoxemia is sufficient to induce monocyte
mobilization from the bone marrow and a prolonged
FIG. 5. A–J) Cytokine levels in the myometrium of untreated mice on E16 and following a laparotomy and intrauterine injection of either PBS or LPS (10
lg of E. coli LPS serotype 0111:B4) at 3 and 7 h postprocedure and in labor. The data are expressed as median interquartile range. Cytokine levels at each
time point were compared using an unpaired t-test when normally distributed and a Mann-Whitney test when not. E16 untreated data were included as a
guide (*P , 0.05, **P , 0.01, ***P , 0.001, n¼ 5–6).
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margination of these monocytes in the lung microvasculature
[24]. Further, O’Dea et al. [23] demonstrated that subclinical
endotoxemia was able to prime the inflammatory marginated
monocytes to a second LPS challenge. The high numbers of
leukocytes sequestered to the maternal lungs and liver at 7 h
post-LPS may be a limiting factor in their recruitment to the
myometrium. This has been previously reported by Andonegui
et al. [25], who demonstrated that when neutrophils are
sequestered in the lungs, they are unavailable for entry into
other sites of infection. A higher dose of LPS would be
expected to increase inflammatory cell mobilization from the
bone marrow, but it would also have a greater effect on the
margination of inflammatory cells into the lung vasculature.
Overall, it is difficult to predict whether the net effect would be
to increase the myometrial inflammatory cell infiltration.
Indeed, the neutrophil and monocyte cell density in the
myometrium was significantly higher after PBS injection than
LPS. This may have been because of the greater systemic
inflammation, as shown by the higher levels of circulating
chemokines and cytokines at all time points, and inflammatory
cell sequestration into the lungs and liver after LPS, but it is
intriguing that the markedly greater myometrial inflammatory
cell infiltration in the PBS group (compared with control or
LPS-injected mice) was not associated with an earlier onset of
labor. This—and the relatively lesser increases (compared to
the 7-h PBS levels) in monocyte and neutrophil numbers in
LPS-induced laboring myometrium—suggests that intrauterine
LPS causes labor through a direct effect on myometrial
function and/or mediated via a TLR4-driven increase in local
inflammation, as has been suggested by in vitro studies [26].
Macrophages may also be a target of LPS action, as they are
present in the uterus and express TLR4 [27]. Our earlier work
showed that inflammatory cytokine levels were increased at 2 h
post-LPS in association with increased COX-2 mRNA
expression at 4 h [16]. In the current study, we found that
myometrial cytokines were increased at 3 and 7 h and in labor,
consistent with these observations. Shynlova et al. [17]
demonstrated that administration of a broad-spectrum chemo-
kine inhibitor significantly delayed LPS-induced PTL and also
reduced the LPS-induced increase in IL-1b, IL-6, IL-12, CSF2,
CCL2, CCL4, CXCL1, and CXCL2 gene expression in the
myometrium, suggesting that inflammatory cell infiltration was
important in the process of labor induction. However, we
previously found that IL-8 alters gene expression in human
FIG. 6. A–J) Circulating cytokine levels of untreated mice on E16 and following a laparotomy and intrauterine injection of either PBS or LPS (10 lg of E.
coli LPS serotype 0111:B4) at 3 and 7 h postprocedure and in labor. The data are expressed as median interquartile range. Cytokine levels at each time
point were compared using an unpaired t-test when normally distributed and a Mann-Whitney test when not. E16 untreated data were included as a guide
(*P , 0.05, **P , 0.01, ***P , 0.001; n¼ 4–6).
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myometrial cells directly, increasing COX-2 and its own
mRNA expression; consequently, a chemokine antagonist
might mediate its effects independent of any reduction in
inflammatory cell infiltration [28]. Moreover, others have
shown that depletion of both circulating neutrophils and Ly-
6CHI monocytes did not delay LPS-induced PTL or term labor,
respectively [14, 29], although depletion of macrophages
(treating mice with anti-F4/80 antibodies) prevented preterm
labor in LPS-treated mice [30]. Macrophages are the most
abundant leucocyte population in the mouse myometrium and
increase with advancing gestation [6]. To assess macrophage
activity, we measured the expression of CD86, a costimulatory
molecule found on the surface of antigen presenting cells,
which correlates with an increase in proinflammatory cytokine
production. In our study, CD86 expression on myometrial
macrophages increased approximately threefold in LPS-
induced labor versus PBS labor, but no increase was seen
prior to labor at the 7-h time point. However, macrophage
depletion prevents LPS-induced parturition [30], suggesting
that these cells play an important role in the process, although
no data showing a reduction in macrophage numbers in the
uterus or cervix were presented. Isolating the infiltrating and
resident populations to assess their functional and phenotypic
characteristics at various stages of pregnancy may provide
further insight into this area.
Different serotypes of LPS have been used in the
intrauterine LPS mouse model of PTL, and this may account
for the inconsistent results. For example, fetal death after an
LPS challenge has been attributed to fetal brain inflammation
[31], but in the current study, we found no evidence of fetal
brain inflammation prior to death. Earlier work from our own
group [31] and from Elovitz et al. [32] found that intrauterine
LPS results in fetal brain inflammation. However, more recent
data from our group indicate that these differences may be
related to the different types of LPS used [19]. While Elovitz et
al. [32] used the E. coli-derived LPS serotype O55 [32],
Pirianov et al. [31] used a salmonella-derived LPS, which has
major differences in both the lipid A and the oligosaccharide-
specific chain of the molecule and which may alter placental
transfer and therefore the fetal inflammatory response.
Consistent with this, in a rat study using LPS 0111 labeled
with I125, none was detected in the fetus, suggesting that LPS
FIG. 7. MAPK phosphorylation levels (A–F) and MAPK/AP-1 and NFjB phosphorylation (G–L) in the myometrium following a laparotomy and
intrauterine injection of either PBS or LPS (10 lg of E. coli LPS serotype 0111:B4). The data are expressed as median interquartile range. The data in graphs
A, C, E, G, I, and K were analyzed using a one-way ANOVA with Bonferroni posttest when normally distributed and a Friedman test and with a Dunn
multiple comparisons post hoc test when not. Data in graphs B, D, F, H, J, and L representing the levels of PBS versus LPS at each time point were
analyzed using an unpaired t-test when normally distributed and a Mann-Whitney test when not (*P , 0.05, **P , 0.01, ***P , 0.001; n ¼ 6).
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0111 does not cross the placenta [33]. Rather, studies in rats
and sheep suggest that LPS induces neonatal brain damage and
causes death through impaired placental perfusion [34, 35].
Our findings are consistent with this, although the cytokine
mRNA expression in the placenta was increased at 3 and 7 h
and markedly elevated in the laboring samples. In contrast,
placental leucocyte infiltration of neutrophils and Ly-6CHI
monocytes was unchanged from controls at 7 h, while at labor,
Ly-6CHI monocyte cell density was actually lower in the LPS-
treated mice despite the increase in cytokine mRNA expres-
sion. If there is an abrupt cessation of blood flow to the
placenta, as has been suggested [34, 35], then this may lead to
an altered pattern of immune response compared to the
situation in the human, where chorioamnionitis is likely to
develop gradually and where placental blood flow does not
appear to be compromised. These are potentially notable
limitations to the ability of intrauterine LPS to reproduce the
changes seen with chorioamnionitis in human pregnancies.
However, a substantial literature suggests that inflammation
plays a role in the onset of human term labor through
upregulation of prolabor genes [36], repression of progesterone
action [37], or a direct effect on myometrial contractility [26,
38]. Indeed, we previously found commonalities between LPS-
induced labor in the mouse and human labor [39], suggesting
that intrauterine LPS may be a reasonable model for human
term labor.
In this study using a murine model of intrauterine LPS-
induced PTL, we found no evidence of a relationship between
labor onset or fetal demise and changes in leucocyte
populations in reproductive tissues and systemic sites.
Generally, this model is used to reproduce the changes seen
with chorioamnionitis in human pregnancies, and while it does
reliably induce labor, our data suggest that this may be through
an increase in myometrial cytokine levels or a direct effect of
LPS on myometrial function rather than an increase in
myometrial inflammatory cell infiltration. Although this
mechanism is probably active in human chorioamnionitis, it
seems likely that inflammatory cells also have an important
role in the onset of chorioamnionitis-associated preterm labor,
meaning that the murine LPS model does not totally reproduce
all of the aspects of human chorioamnionitis [38]. Further, in
this study, despite placental inflammation, fetal death occurred
without evidence of preceding fetal inflammation and may
have been caused by a reduction in placental perfusion [40]. In
contrast, in the human, inflammation plays a prominent role in
the fetal compromise [41, 42]. Overall, our data suggest that
the intrauterine LPS mouse model reproduces some but not all
of the features of human chorioamnionitis.
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